Análisis de la subasta inversa corporativa de medicinas y su impacto en desempeño financiero de la industria farmacéutica de Quito registrada en la superintendencia de compañías valores y seguros, periodo 2015-2018

Abstract

The present research paper analyzes the impact that the implementation of the Corporate Reverse Medicines Auction has had on the financial performance of the Ecuadorian pharmaceutical industry through a descriptive, exploratory, information and data research collected from primary sources through surveys, analysis of financial and economic data provided by public and private entities that are related to the sector under analysis. In addition to secondary sources, such as sector studies generated by the academy and trade associations, which has allowed us to identify the important contribution that this public procurement mechanism has made to the development of the pharmaceutical sector both nationally and domiciled in the city of Quito in the 2015-2018 period, which resulted in an increase in the participation of this industry in the national market, its sales and a moderate maintenance of the financial indicators, accompanied by a commitment to productive and technological investment to improve competitiveness with international markets and meeting the needs of both the private and institutional local market shows a positive contribution of this auction mechanism in the development and expectations of the sector.